ClinicalTrials.gg
RecruitingNCT07569458MY-CHOICEUpdated May 6, 2026

Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)

An interventional study of Online psychological therapy in Ischemic Heart Disease (IHD), Anxiety and Depression, sponsored by University of Southern Denmark. Recruiting at 3 sites in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-06.

Sponsored by University of Southern Denmark · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Jul 2025, registered Mar 2026).
  • Started Jul 2025; still recruiting 1 year 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 95 studies in Myocardial Ischemia with a site in Denmark — 20 open to participants now, 25 under way, 2 of them phase 3. Myocardial Ischemia · Denmark.

Planned enrollment
69th of 75
30 · median 300
Started
2025
with 3 others
No phase
48 of 95
10 open now
Primary completion
2026-10
later than 9 of 24 live
Registered
94th of 95
by date

Among the 95 studies in Myocardial Ischemia with a site in Denmark, this one is the 69th largest by planned enrollment of the 75 interventional ones that give a count, is one of 4 that started in 2025, is one of 48 with no phase, reaches primary completion later than 9 of the 24 other live ones, and was the 94th registered.

Myocardial Ischemia

1,123 studies on the registry are indexed under Myocardial Ischemia; 177 are open to participants now.

Browse Myocardial Ischemia studies →

Open to participants now

20 of the 95 studies in Myocardial Ischemia with a site in Denmark are open now. Recruiting first, the newest first:

14 more — sign in →

All 20 open studies →

A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →

Who these studies take

Of the 135 Myocardial Ischemia studies recruiting now, 92 (68%) set no upper age limit and 6 (4%) stop at 75 or younger; 14 take children under 18; 20 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 95 studies in Myocardial Ischemia with a site in Denmark, or all of them as a file.
02

Study summary

The goal of this feasibility study is to assess if the personalised online psychological intervention MY-CHOICE is acceptable to adults with ischemic heart disease and anxiety or depression. It will also examine the reasons for drop-out. The main questions the study aims to answer are:

How many participants complete the intervention and what are the reasons for drop-out. And what are the pre-post change scores on anxiety and depression.

Participants will:

Complete the MY-CHOICE intervention consisting of 6-12 weeks with online modules on various topics based on individual needs in combination with video- or telephone calls with a therapist (psychologist or a trained master student in Psychology) on a need-to basis.

Answer a set of questionnaires pre and post intervention. Participate in a brief interview post intervention.

Read the detailed description

The MY-CHOICE project will assess the feasibility of a therapist-assisted eHealth intervention on patient satisfaction and dropout (barriers and facilitators), quality of life, and procedures with respect to recruitment and implementation in the CR settings. It is hypothesized that a therapist-assisted eHealth intervention that is personalized to patients' needs and preferences and that allows patients to engage in the intervention when and where they want, may reduce patients' barriers for seeking and engaging in treatment (e.g. drop-out).

Study design The MY-CHOICE intervention is a new comprehensive eHealth program for patients with IHD based on the premise of personalized medicine.

The intervention targets depression, anxiety and other common challenges met by patients with IHD attending CR that have been shown to impact on patients' quality of life, prognosis, motivation for self-care, compliance, and risk factor management.

Using a pre- post-test design, the study will examine the feasibility of (i) the intervention in 30 patients with IHD and co-morbid depression and/or anxiety referred to CR at one of the participating sites, including asking patients about the reason for drop-out at the time of drop-out, and (ii) evaluate the procedures for recruitment at the participating CR sites with respect to conducting a potential RCT and future implementation in routine care. Post intervention, investigators will ask all patients and 3-6 members of the CR team to complete a set of questions online related to identify barriers and facilitators for implementing the intervention in clinical care at a patient and organizational level.

Study population Patients will be recruited from cardiac rehabilitation centers in Denmark.

Study aims The primary aim of the study is to explore how patients experience and react to the intervention. We assess patients´ adherence, drop-out rate and treatment satisfaction.

The secondary aim is to assess the limited efficacy measured as the change in score on anxiety and depression (HADS) from baseline to 3-month follow-up.

MY-CHOICE intervention The intervention will partly be built on the principles of Cognitive Behavioral Therapy but also include core elements from several other psychological therapies like Acceptance and Commitment Therapy, Compassion Focused Therapy, existential psychology and Metacognitive Therapy. All patients will receive 4 mandatory core treatment modules for depression and anxiety. However, as the intervention is flexibly targetable to the individual patient's needs and preferences, and also designed to include and retain socially vulnerable patients and patients at risk of drop out - patients will choose the other modules and topics that they want to work with in a dialogue with the therapist. A flexible treatment is preferred, because each patient's life and symptom composition are different. The rationale is that an intervention tailored towards the specific anxiety and depression symptoms experienced by the individual patient is thought to be more effective than a one-size-fits all intervention.

There is a total of 13 optional modules, and depending on the treatment duration, patients will have time to complete 3-8 optional modules. The choice of modules can be adapted during the intervention, as patients' needs may change over time. After reading a short description of the optional modules, patients will be asked to indicate their preferred modules. When patients have expressed their preferences, they will talk to their therapist, who will help them decide between the optional modules.

Patients will work through the different modules, guided and supported by a therapist through asynchronous text messages. Motivational interviewing will be an integral part of the intervention to prevent drop-out. Treatment progress will be monitored every week by means of symptom questionnaires (CORE-10) that patients complete online via the platform. This information will be used in a dialogue between patients and therapists to steer the intervention, with adaptations made, if the expected progress is not seen. Therapists may contact patients via telephone during the intervention if needed. In addition to the 17 psychological intervention modules (4 mandatory, 13 optional), there will be 3 optional modules, focused on physical health and risk factor management (i.e. exercise, diet, and smoking). These modules will be offered to patients if they need more help after completing a psychologically focused module about lifestyle changes. The therapist can refer the patient to our Health Coach (HC) who is a trained physiotherapist educated in smoking cessation and diet. The HC will assess what kind of help the patient needs (e.g. refer the patient to existing treatment in the municipalities or the CR setting), or if the patient needs more, they can be offered to complete one or several of the health modules. Like the therapists, the HC will communicate with the patients by video call/phone, or written messages on the treatment platform.

All patients will have access to the material of the intervention so that they can revisit and reuse it on a need-to basis until 4 weeks after the last patient has completed the intervention. The eHealth intervention will be delivered by psychologists and master level students in psychology all employed at SDU and specialized in online psychology. The online platform (Minddistrict.com), is GDPR compliant and users log in using two-factor-authentication.

As part of the intervention, patients will be asked to complete the CORE-10 questionnaire every week to evaluate the patient's progress. Item 6 considers frequency of suicidal plans and is used as a continuous measurement of the suicidal risk of the patient. Any score above 0 will result in preventive actions from the therapist.

Procedure Within 2 weeks after discharge for an acute event from the hospital, patients with IHD are referred to a 12-week CR program. As part of current clinical practice, patients are screened for symptoms of depression and anxiety with the HADS or with the WHO-5 + MDI-2 and ASS-2 depending on the standard procedures of the site. Given that there is often a time lag between hospital referral of the patient to CR and the time that the patient can start the CR program, study procedures ensure that patients referred with a positive screening still have a positive screening at the time of inclusion into the study. Staff at the participating sites will obtain written informed consent prior to inclusion. Patients who consent will receive the baseline questionnaire package online, including the HADS, and will be contacted by telephone by one of the therapists after completion. If the HADS is negative the patient will be excluded and if positive the therapist will 1) seek to exclude major psychopathology including high suicidal risk and 2) assess whether the patient is likely to adhere to- and benefit from the treatment based on motivation, available time and energy, writing/reading capabilities and IT literacy. The interview is a standardized telephone interview, partly based on the psychiatric interview Schedules of Clinical Assessment in Neuropsychiatry (SCAN). If the therapist concludes the patient is not eligible based on the previous two criteria the patient will be excluded. If eligible, the patient will be offered the intervention and receive an appointment for a telephone-based start interview with the assigned therapist. In the start interview patients' individual symptoms of anxiety and depression will be mapped by the therapist, who will suggest how MY-CHOICE could be tailored to the patients' individual symptoms and psychological needs.

Measures and data collected The participating centers will search the patients´ medical records to determine whether patients are eligible to participate based on the inclusion and exclusion criteria. To document in/exclusion criteria this information (i.e., severe psychiatric disorder (borderline disorder, schizophrenia or bipolar disorder) (y/n), severe cognitive difficulties (y/n)), will be registered in the project database REDCap along with the patients´ planned rehabilitation (physical training, patient education, diet, and/or smoking cessation) and medical treatment for IHD (Percutaneous coronary intervention, Coronary artery bypass surgery and/or medication) for description of the study population. If patients sign the informed consent form, or want time to consider participation, their CPR-number, name, and telephone number will be registered in the project database, to enable the research team and the therapists to contact the patients who have consented to participate and to send a link to the electronic consent form to patients with time to consider. Further information on patients' demographic and clinical characteristics will be captured from purpose-designed questions in the questionnaire. Information on patients' use of the platform (e.g. time spent on platform, exercises completed) will be obtained from logging on the GDPR secure platform. All patients will complete the questionnaires at baseline and 3-months' follow-up to (i) indicate priorities for patients to work on, and (ii) use as outcome measures (see Table 1).

Data analyses The analyses will focus on assessing the limited efficacy, drop-out, adherence, and acceptability of the intervention. Due to the exploratory nature of the feasibility study, a formal power analysis was not conducted, and the sample size was determined pragmatically.

To evaluate limited efficacy, changes from baseline to 3 months follow-up on HADS-A and HADS-D will be analyzed, focusing on mean change scores as well as the proportion of study participants achieving a change score of at least 2-points, thus exceeding the minimal clinically important difference (MCID) of the HADS (36). Change score analyses will also be conducted for the Perceived Stress Scale (PSS) and Heart QoL to examine pre- to post-intervention differences.

Drop-out rates and loss to follow-up will be evaluated and summarized as counts and proportions. Adherence will be evaluated based on participants´ engagement with the intervention. Patient satisfaction with the eHealth intervention will be assessed using the 6-item Internet evaluation and usability questionnaire. To further examine acceptability, purpose-designed, qualitative open-ended questions evaluating the intervention will be collected at 3-month follow-up and explored using content analysis to identify key themes related to patients' experiences. Additionally, 6-10 patients will be interviewed post-intervention to add in-depth information about patients´ experiences with the intervention. Interviews will be transcribed and analyzed using Template Analysis.

Results from the quantitative measures will be presented descriptively, using means, standard deviations, ranges, frequencies, and proportions as appropriate.

The statistical analyses will be carried out using R statistical software.

03

Conditions studied

  • Ischemic Heart Disease (IHD)
  • Anxiety
  • Depression

Keywords

  • online intervention
  • psychological intervention
  • ischemic heart disease
  • treatment of anxiety and depression
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ischemic heart disease (diagnostic codes I20-I25),
  • referred for CR with a positive screen for depression and/or anxiety with the Hospital Anxiety and Depression Scale (HADS ≥ 8)
  • access to and ability to use a computer or tablet
  • proficient in the Danish language

Exclusion criteria

Exclusion Criteria:

  • Severe psychiatric disorder (i.e., borderline disorder, schizophrenia or bipolar disorder) that requires psychiatric care
  • severe cognitive difficulties (e.g., severe brain damage, mental retardation, or dementia) that will prevent patients from participating
  • endorsement of suicidal ideation with suicidal thoughts (purpose designed questions) that cannot be handled in the intervention
  • participation in other intervention studies focused (unless they are clinical studies)
  • seeing a psychologist or mental health professional for the treatment of anxiety and depression
  • not being able or willing to spend 3-4 hours on the intervention each week
  • experiencing significant life stressors that hinder adherence to the MY-CHOICE treatment
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Psychological intervention

    Online psychological intervention for anxiety and depression, tailored to the patients´ individual needs. Duration 6-12 weeks. The psychological intervention is provided as add-on to treatment as usual (i.e., the patients´ individual medical treatment and rehabilitation program.)

    Other: Online psychological therapy

Interventions

  • OtherOnline psychological therapy

    Online psychological treatment of anxiety and depression for patients with ischemic heart disease tailored to individual needs. The treatment includes access to an online treatment platform offering psychological content and written communication with the therapist and telephone-video conversations with the therapist. The intervention is tailored to meet the patients´ individual needs.

06

What researchers measure

Primary outcomes

  1. Drop-out rate

    Time frame: From enrollment to end of treatment i.e., from 0 to 13 weeks

Secondary outcomes

  1. Limited efficacy on depression (HADS-D)

    Limited efficacy: changes from baseline to 3 months follow-up on Hospital Anxiety and Depression Scale - Depression (HADS-D) will be analyzed, focusing on mean change scores as well as the proportion of study participants achieving a change score of at least 2-points in any direction. HADS-D have a score range of 0-21 with lower score indicating better outcome.

    Time frame: From baseline to completion of 3-month follow-up which is administered after 13 weeks.

  2. Limited efficacy Anxiety (HADS-A)

    Limited efficacy: changes from baseline to 3 months follow-up on Hospital Anxiety and Depression Scale - Anxiety (HADS-A) will be analyzed, focusing on mean change scores as well as the proportion of study participants achieving a change score of at least 2-points. HADS-A have a score range of 0-21 with lower score indicating better outcome.

    Time frame: From completion of baseline questionnaire to completion of post intervention questionnaire administered 13 weeks after enrollment.

  3. Patient satisfaction with intervention

    Patient satisfaction with the eHealth intervention will be assessed using the 6-item Internet evaluation and usability questionnaire. (Range 0-24 and higher score indication higher satisfaction)

    Time frame: Administered in the FU-questionnaire 13 weeks after enrollment

  4. adherence to intervention

    Adherence will be evaluated based on participants´ engagement with the intervention. Each intervention module assigned to the individual patient will be rated as either completed or not by the therapist based on patients' activity on the platform and information from the video-/phone therapy sessions.

    Time frame: immediately after completion of intervention. i.e. between 6 and 12 weeks depending on the length of intervention. Possibly sooner if a patient drops out.

  5. Limited efficacy on stress

    Change score analyses will be conducted for the Perceived Stress Scale (PSS) to examine pre- to post-intervention differences. The PSS has a range of 0-40 with a higher score indicating higher levels of perceived stress

    Time frame: Administered in the FU-questionnaire 13 weeks after enrollment

  6. Limited efficacy on quality of life

    Change score analyses will be conducted for Heart QoL to examine pre- to post-intervention differences. Heart QoL has a range of 0-42 with higher scores indication better outcome

    Time frame: Administered in the FU-questionnaire 13 weeks after enrollment

07

Study locations

3 of 3 sites recruiting
  • Aalborg University Hospital, Department of Cardiology
    Aalborg, 9000, Denmark
    Recruiting
    • Pia Behrndtz, Head nurse · Contactpib@rn.dk · +45 21 53 13 49
    • Bent Raungaard, MD · Principal investigator
  • Aarhus University Hospital, Department of Cardiology
    Aarhus, 8200, Denmark
    Recruiting
    • Helle L Kanstrup, MD · ContactHelle.kanstrup@rm.dk · +45 78 45 20 20
    • Helle L Kanstrup, MD · Principal investigator
  • Zealand University Hospital, Roskilde, Department of Cardiology
    Roskilde, 4000, Denmark
    Recruiting
    • Kirsten Charlotte Helmark, PhD · Contactkche@regionsjaelland.dk · +45 4732 6111
    • Kirsten Charlotte Helmark, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Oct 2026, 14 months after the start.

Of 155 non-industry interventional studies with no phase under Myocardial Ischemia, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 56. This study's planned 14 months is below that.

Counting every sponsor, half of 192 studies reached it within 34 months; a quarter within 15 and three quarters within 58.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 25, 2026
First posted
May 6, 2026
StartActual
Jul 4, 2025
Primary completionEst.
Oct 1, 2026
CompletionEst.
Oct 2026
Last update
May 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07569458
Collaborators
Aarhus University Hospital Skejby, Aalborg University Hospital, Zealand University Hospital
Responsible party
Sponsor
First posted
May 6, 2026
Start date
Jul 4, 2025
Primary completion
Oct 1, 2026 (estimated)
Completion
Oct 2026 (estimated)
Last update
May 6, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion